Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Quick Takeaways Retatrutide is a triple-receptor agonist (GLP-1, GIP, glucagon) delivering superior monotherapy weight loss at 2428.7% over 4868 weeks Cagrilintide targets amylin receptors for satiety and gastric emptying, achieving 10.8% weight loss in 26 weeks as a monotherapy Retatrutide provides broader metabolic benefits, including dramatic improvements in HbA1c, blood pressure, waist circumference, insulin sensitivity, and liver fat normalization No head-to-head trials exist yet, but the mechanistic and clinical data strongly favor Retatrutide for total body recomposition Retatrutide vs Cagrilintide: Side-by-Side Comparison What Makes Retatrutide Different Retatrutide isnt just another GLP-1 receptor agonist
The conjugation of glutathione on the previously hydrophobic-toxic substrate results in a soluble compound, which is more readily exocytosed by the cell
Concentration = vial mcg / water mL Dose volume = target dose mcg / concentration U-100 units = dose volume mL x 100 Semaglutide 5 mg vial with 2 mL example A 5 mg semaglutide vial mixed with 2 mL gives a concentration of 2.5 mg/mL, or 2,500 mcg/mL
How many units of GHK-Cu do I draw
US$ 25.25
US$ 25.82
US$ 24.82
US$ 26.23
US$ 23.71
US$ 20.66
